Back to today’s briefing

Story perspectives

Prosecons Neuroscience Wins FDA Approval for BCI Breakthrough

4/21/2025

31 7

Summary

Story summary

Neurotech startup Prosecons Neuroscience has achieved a groundbreaking milestone with FDA approval for a vital part of its brain-computer interface (BCI) system, designed to help paralyzed patients regain speech and movement. This achievement not only highlights Prosecons' innovative journey over four years but also positions it alongside industry giants like Neuralink and Synchron.

1 of 1

Story summary

Neurotech startup Prosecons Neuroscience has achieved a groundbreaking milestone with FDA approval for a vital part of its brain-computer interface (BCI) system, designed to help paralyzed patients regain speech and movement. This achievement not only highlights Prosecons' innovative journey over four years but also positions it alongside industry giants like Neuralink and Synchron.